ACLX
|
Arcellx, Inc.
|
US
|
NASDAQ
|
ADAG
|
Adagene Inc.
|
US
|
NASDAQ
|
AFMD
|
Affimed Therapeutics B.V.
|
US
|
NASDAQ
|
ALPN
|
Alpine Immune Sciences, Inc.
|
US
|
NASDAQ
|
BLCM
|
Bellicum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
EVAX
|
Evaxion Biotech A/S
|
US
|
NASDAQ
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
GOVX
|
GeoVax Labs, Inc.
|
US
|
NASDAQ
|
GRTS
|
Gritstone Oncology, Inc.
|
US
|
NASDAQ
|
HCWB
|
HCW Biologics Inc.
|
US
|
NASDAQ
|
IMCR
|
Immunocore Holdings plc
|
US
|
NASDAQ
|
IMNN
|
Imunon, Inc.
|
US
|
NASDAQ
|
IMTX
|
Immatics N.V.
|
US
|
NASDAQ
|
IMV
|
IMV Inc.
|
US
|
NASDAQ
|
KA
|
Kineta, Inc.
|
US
|
NASDAQ
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
NBTX
|
Nanobiotix S.A.
|
US
|
NASDAQ
|
NEXI
|
NexImmune, Inc.
|
US
|
NASDAQ
|
ONCR
|
Oncorus, Inc.
|
US
|
NASDAQ
|
PDSB
|
PDS Biotechnology Corporation
|
US
|
NASDAQ
|